In the late phase (BD + 5h), methylprednisolone pretreatment was associated with decreased lung gene expression for IL-10, IL-1β, TNF-α, IL-8 and pro-inflammatory IL-6/IL-10 (p<0.05 compared to placebo-treated brain death). This evidence concerns the gene IL1B and Behcet disease.